160237-99-0Relevant articles and documents
4-Formylazetidin-2-one as a useful building block for the formal synthesis of xylo-(2S,3R,4R)-phytosphingosine and threo-(2S,3S)-sphingosine
Kale, Ajaykumar S.,Sakle, Prathmesh S.,Gumaste, Vikas K.,Deshmukh, Abdul Rakeeb A. S.
, p. 2631 - 2636 (2008/02/13)
Stereoselective formal synthesis of xylo-(2S,3R,4R)-phytosphingosine and threo-(25,35)-sphingosine is described starting from an enantiopure formyl-substituted β-lactam. Grignard reaction of the N-Boc-protected- β-lactam carbonyl group, followed by furthe
Facile conversion of 2-azetidinones to 2-piperidones: Application to a formal synthesis of Prosopis and Cassia alkaloids
Lee, Hyeon Kyu,Chun, Jong Soo,Pak, Chwang Siek
, p. 6445 - 6454 (2007/10/03)
Nonracemic 5,6-disubstituted 2-piperidones were prepared from readily accessible 3,4-disubstituted-2-azetidinones having pre-installed substituents by reductive ring opening of 2-azetidinones followed by stereoselective installation of Z-α,β-unsaturated ester and lactam formation. For the synthetic application to the naturally occurring piperidine alkaloids, such as Prosopis and Cassia alkaloids, 5-hydroxy-2-piperidones (+)-13 and (-)-24 were prepared from 2-azetidinones (-)-6b and (+)-18 via two-carbon ring homologation.
Facile transformation of 3,4-disubstituted 2-azetidinones to chiral 5,6-dihydro-2-pyridones
Lee, Hyeon Kyu,Chun, Jong Soo,Pak, Chwang Siek
, p. 3483 - 3486 (2007/10/03)
Chiral 5,6-disubstituted-5,6-dihydro-2(1H)-pyridones were prepared efficiently from readily accessible 3,4-disubstituted-2-azetidinones having preadjusted substituents and stereochemistry through the reductive ring opening of 2-azetidinones followed by Z-selective installation of acetate moiety and re-cyclization to 2-pyridones.
Synthesis and Biological Evaluation of C-3'-Modified Analogs of 9(R)-Dihydrotaxol
Li, Leping,Thomas, Sheela A.,Klein, Larry L.,Yeung, Clinton M.,Maring, Clarence J.,et al.
, p. 2655 - 2663 (2007/10/02)
Taxol (1) is considered a most exciting new drug in cancer chemotherapy.The promising antitumor activity of 9(R)-dihydrotaxol (3) encouraged us to further explore the structure-activity relationship of this new member of the taxane family.Studies indicate